231 reports of this reaction
1.5% of all CRISABOROLE reports
#17 most reported adverse reaction
SKIN BURNING SENSATION is the #17 most commonly reported adverse reaction for CRISABOROLE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 231 FDA adverse event reports linking CRISABOROLE to SKIN BURNING SENSATION. This represents approximately 1.5% of all 15,699 adverse event reports for this drug.
Patients taking CRISABOROLE who experience skin burning sensation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SKIN BURNING SENSATION is a less commonly reported adverse event for CRISABOROLE, but still significant enough to appear in the safety profile.
In addition to skin burning sensation, the following adverse reactions have been reported for CRISABOROLE:
The following drugs have also been linked to skin burning sensation in FDA adverse event reports:
SKIN BURNING SENSATION has been reported as an adverse event in 231 FDA reports for CRISABOROLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SKIN BURNING SENSATION accounts for approximately 1.5% of all adverse event reports for CRISABOROLE, making it a notable side effect.
If you experience skin burning sensation while taking CRISABOROLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.